BioMed Realty Announces 2023 ESG Achievements

BioMed Realty is a portfolio company within Blackstone’s Core+ Life Sciences Real Estate strategy, which achieved a 5 Star Rating in the 2023 GRESB Real Estate Assessment.

More News

Press Release

Full-building, 15-year lease for 64,000 square feet enables CDMO CordenPharma Colorado to power next-generation peptide development

Search BioMed